Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,545 across all filing types
Latest filing 2026-04-26 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - CSL 6 pages 18.2KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C ‘Notification of buy-back’ providing daily on-market share buy-back details (quantities, prices, dates). This is a report on the company’s own share transactions (buy-back). Therefore, it falls under Transaction in Own Shares (POS).
2026-04-26 English
Update - Notification of buy-back - CSL 6 pages 18.2KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C “Notification of buy-back” providing detailed daily on-market share buy-back statistics (securities bought back, prices, dates, broker details). This is a direct report of the company’s transaction in its own shares, matching the definition of share repurchase/issuance. Therefore it is classified as a Transaction in Own Shares (POS).
2026-04-23 English
Update - Notification of buy-back - CSL 6 pages 18.2KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C ‘Notification of buy-back’ (daily on-market share buy-back) by CSL Limited, detailing the number of shares repurchased, prices paid, dates, broker, and buy-back program parameters. This is a report of the company buying back its own shares. This matches the definition of Transaction in Own Shares (Code: POS).
2026-04-22 English
Update - Notification of buy-back - CSL 6 pages 18.2KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C “Notification of buy‐back” reporting daily on-market share repurchases by CSL Limited, including volumes, prices, and cumulative totals. This is a report of the company buying back its own shares, matching the definition for “Transaction in Own Shares” (Code: POS).
2026-04-21 English
Update - Notification of buy-back - CSL 6 pages 18.2KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C notification detailing daily on-market buy-back activity by CSL Limited, including numbers of shares repurchased, prices paid, and key dates. This is a report of the company buying back its own shares, matching the “Transaction in Own Shares” category.
2026-04-20 English
Notification of cessation of securities - CSL 4 pages 14.6KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3H form notifying the cessation (lapse) of rights securities, which directly alters the entity’s issued capital structure. This is not a full report but a specific announcement of a capital change. Therefore, it falls under ‘Share Issue/Capital Change’ (SHA).
2026-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.